Friday, October 30, 2020

US$60 experimental vaccine rolled out in east Chinese city

China is desperate to win the global race for a vaccine against the virus which emerged in the central city of Wuhan.

Other News

799 kes baru Covid-19, 491 dilaporkan pulih

Angka keseluruhan Covid-19 kini berjumlah 30,889 kes.

799 new cases, 3 more deaths

466 of the new cases reported in Sabah.

Itulah kebebasan bagi mereka, kata Dr Mahathir selepas Twitter memadam tulisannya

Twitter memadamkan komen Mahathir selepas pemerintah Perancis membantah petikan tulisannya.

That’s freedom to them, says Dr M on Twitter censorship

The former PM says his comments were taken out of context.

Pendaftaran Pejuang masih dalam semakan, kata RoS

Pendaftaran Pejuang belum diluluskan selepas lebih dua bulan permohonan bertulis dan secara dalam talian dikemukakan kepada RoS.

A US$60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine.

Officials in Jiaxing city said Thursday residents aged between 18 and 59 with “urgent needs” can seek consultations at clinics for a Sinovac Biotech vaccine that authorities have been giving to groups such as medical workers.

The statement from Jiaxing’s centre for disease control and prevention did not specify what constituted “urgent needs”.

Authorities did not say how many people in the city had been given the vaccine, which comes in two doses, administered up to 28 days apart and costing a total of 400 yuan (US$59).

China has already given hundreds of thousands of essential workers at ports, hospitals and other high-risk areas across the country an experimental vaccine, according to officials.

But even as 11 Chinese vaccines have entered clinical trials – with four in advanced Phase Three trials – none have been approved for mass market distribution.

China is desperate to win the global race for a vaccine against a virus which emerged in the central city of Wuhan, as it seeks to complete its narrative of recovery from the public health and economic calamity.

China has approved some candidates for emergency use, with officials saying they have not seen serious adverse reactions.

Beijing has also made bold predictions on a broader rollout before year-end as it battles a storm of international criticism over its early handling of the outbreak.

Health officials told a press conference last month that the country expects to be able to produce 610 million vaccine doses annually by year-end, stressing it would be affordable.

Chinese President Xi Jinping has also previously declared that Chinese vaccines would be made a “global public good”.

China has signed up to a World Health Organization-led bid to ensure future Covid-19 vaccines are distributed to developing countries, the biggest economy yet to join the attempt to control the pandemic.

Beijing has not given details on how much money it would commit to the deal, which has a fundraising goal of US$2 billion and aims to provide 92 low and middle-income countries with a future vaccine.

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

799 new cases, 3 more deaths

466 of the new cases reported in Sabah.

WHO in Europe says virus lockdowns should be ‘last-resort’

Downsides to national lockdowns include poor mental health, increases in domestic violence and damage to the economy, WHO warns.

France, Germany head towards lockdown as virus surges in Europe

France and Germany are now taking bold steps to shut down social life in the face of spiking infections across the continent.

New cases dip to 649, zero deaths

Total confirmed infections cross 30,000 mark.

801 new cases, death toll up by 8

573 more patients discharged.